Compare PTEN & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTEN | PRCT |
|---|---|---|
| Founded | 1978 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.8B |
| IPO Year | 1993 | 2021 |
| Metric | PTEN | PRCT |
|---|---|---|
| Price | $7.08 | $30.61 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 9 |
| Target Price | $7.25 | ★ $51.13 |
| AVG Volume (30 Days) | ★ 10.4M | 1.1M |
| Earning Date | 02-04-2026 | 02-24-2026 |
| Dividend Yield | ★ 4.50% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $4,837,946,000.00 | $299,907,000.00 |
| Revenue This Year | N/A | $48.30 |
| Revenue Next Year | N/A | $29.44 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 50.07 |
| 52 Week Low | $5.10 | $27.80 |
| 52 Week High | $9.58 | $84.46 |
| Indicator | PTEN | PRCT |
|---|---|---|
| Relative Strength Index (RSI) | 67.18 | 41.81 |
| Support Level | $7.00 | $29.62 |
| Resistance Level | $7.46 | $35.20 |
| Average True Range (ATR) | 0.30 | 1.60 |
| MACD | 0.07 | -0.29 |
| Stochastic Oscillator | 78.37 | 15.92 |
Patterson-UTI Energy Inc is one of the substantial land rig drilling contractors in the United States. Its 2023 merger with NexTier greatly expanded its pressure pumping operations, as well, and the firm now controls nearly 20% of the North American market for drilling and completions services. The company operates under three reportable business segments: (i) drilling services, (ii) completion services, and (iii) drilling products. It also provides directional drilling services and tool rental services in united states onshore oil and gas basins.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.